Sign inJoin waitlistJoin the waitlist

Mark Olsen

Medical Oncologist · Oklahoma Cancer Specialists and Research Institute

Credentials: · · · ·

History

Oklahoma Cancer Specialists and Research Institute
Present

University of Wisconsin Hospitals and Clinics
1995–1997
University of Wisconsin School of Medicine and Public Health
1992–1995
McArdle Laboratory for Cancer Research at the University of Wisconsin
Univ of Wisconsin Sch of Med and Public Health
1988–1992

Research

PointBreak: a randomized phase III study of pemetrexed plus carboplatin and bevacizumab followed by maintenance pemetrexed and bevacizumab versus paclitaxel plus carboplatin and…
Journal of Clinical Oncology · 2013 · 306 citations
Randomized phase II trial of sunitinib on an intermittent versus continuous dosing schedule as first-line therapy for advanced renal cell carcinoma
Journal of Clinical Oncology · 2012 · 227 citations
Safety and Efficacy of Nivolumab in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma: Results From the Phase IIIb/IV CheckMate 374 Study
Clinical Genitourinary Cancer · 2020 · 78 citations

Philip Bonomi
4 papers
Ana Molina
3 papers
CR
Craig Reynolds
3 papers
DS
David Spigel
3 papers
EA
Edward Arrowsmith
3 papers
Edward Garon
3 papers
Jyoti Patel
3 papers
MS
Mark Socinski
3 papers
Ramaswamy Govindan
3 papers
RH
Robert Hermann
3 papers
SG
Susan Guba
3 papers
TH
Thomas Hutson
3 papers